Related Experiment Video
Updated: May 28, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
RNA replicons - a new approach for influenza virus immunoprophylaxis
1Institute of Virology and Immunoprophylaxis (IVI), Sensemattstrasse 293, CH-3147 Mittelhäusern, Switzerland.
Abstract:
RNA replicons are derived from either positive- or negative-strand RNA viruses. They represent disabled virus vectors that are not only avirulent, but also unable to revert to virulence. Due to autonomous RNA replication, RNA replicons are able to drive high level, cytosolic expression of recombinant antigens stimulating both the humoral and the cellular branch of the immune system. This review provides an update on the available literature covering influenza virus vaccines based on RNA replicons. The pros and cons of these vaccine strategies will be discussed and future perspectives disclosed.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Inhibitors Of Virion Release
Leaky Scanning
Respiratory Syncytial Virus Disease
Influenza

